The National Myelodysplastic Syndromes (MDS) Study
Study Number: NHLBI MDS
Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.
- Navigator Heather, 309-243-3661 email@example.com
- Hannah, 309-243-3628 firstname.lastname@example.org